ABSTRACT
INTRODUCTION
Burkholderia species is a Gram-negative bacilli bacterium with over 70 types of subspecies found in a wide range of ecological niches, many of which share similarities in their biochemical and morphological characteristics (Coenye and Vandamme, 2006) . Some of the Burkholderia spp. are pathogenic to plants (Stoyanova et al., 2007) , while others such as Burkholderia pseudomallei which causes melioidosis and Burkholderia mallei which causes glanders, are both pathogenic and potentially fatal to humans and animals (Wiersinga et al., 2012) . Apart from that, Burkholderia cepacia has been reported to cause opportunistic infections in individuals suffering from cystic fibrosis and chronic granulomatous disease (Coenye and Vandamme, 2006) .
Burkholderia pseudomallei is inherently resistant to myriad antibiotics such as β-lactams, aminoglycosides and macrolides, conferred through various mechanisms including inactivating enzymes, cell exclusion, and broadrange efflux pumps (Dance et al., 1989; Simpson et al., 1999; Jenney et al., 2001) . However, unlike what has been reported in other melioidosis endemic countries, over 80% B. pseudomallei strains in Sarawak were found to be susceptible towards aminoglycosides and macrolides (Podin et al., 2014) . Apart from a previous report of B. cepacia being resistant to tobramycin (Kennedy et al., 2015) , there is little knowledge on the antibiotics susceptibility profile of other Burkholderia spp.
It has been previously established that recombination and lateral gene transfer may occur between B. pseudomallei and other Burkholderia spp. that are sharing the same ecological niche which have led to greater intraspecies diversity (Kim et al., 2005; Tuanyok et al., 2007) . This brings about the question of whether such intraspecies interactions include the antibiotics susceptibility mechanisms and whether there are similarities of antibiotics susceptibility profile between B. pseudomallei and other Burkholderia spp. Hence, the objective of this study is to investigate the antibiotics susceptibility profile of Burkholderia spp. isolates of Sarawak origin.
MATERIALS AND METHODS

Bacterial strains
Burkholderia spp. isolates, some of which were archival from a previous study, were used for this project. The strains were isolated from water and soil samples collected from various melioidosis-endemic districts in Sarawak and were identified by the previously described recA gene DNA sequencing method (Payne et al., 2005) .
Antibiotics susceptibility testing
Antibiotics susceptibility testing was performed using the standard disk diffusion test method using disks purchased from Liofilchem (Liofilchem, Italy). The antibiotics selected for this study were clinically relevant to B. pseudomallei in Sarawak namely, gentamicin, azithromycin, cotrimoxazole (trimethoprim/sulfamethoxazole) and ceftazidime. The minimal inhibitory concentration (MIC) breakpoints were determined based on the Clinical and Laboratory Standard Institute (CLSI) guidelines (CLSI, USA).
RESULTS AND DISCUSSION
As shown in Table 1 , 81 Burkholderia spp. isolates of eight types of subspecies commonly found in the environment in Sarawak were subjected to disk diffusion test. A majority of the isolates belong to the subspecies Burkholderia pyrrocinia, B. thailandensis and B. ubonensis. Figure 1 depicts the antibiotics susceptibility of the tested isolates against azithromycin. Of the 20 B. thailandensis isolates tested, 65% appeared to be resistant against azithromycin. Five out of 7 isolates belonging to the B. cepacia complex group were resistant towards azithromycin. Burkholderia ubonensis on the other hand, were mostly susceptible to azithromycin with 79% of 14 isolates, while B. pyrrocinia had almost equal number of isolates that belonged to the susceptible and intermediate category.
Aminoglycoside and macrolide susceptibility
The antibiotics susceptibility of Burkholderia spp. against gentamicin is shown in Figure 2 . Almost all the subspecies tested were predominantly resistant against gentamicin. The only subspecies that has equal number of isolates resistant and susceptible to gentamicin was B. ubonensis. Burkholderia cepacia on the other hand had equal number of isolates that were intermediately susceptible and resistant towards gentamicin.
Azithromycin belongs to the macrolide drug group while gentamicin is an aminoglycoside, both of which have been previously described as antibiotics that B. pseudomallei were intrinsically resistant against (Simpson et al., 1999; Coenye and Vandamme, 2006) . However, the strains from central Sarawak have been shown to be more than 80% susceptible to both aminoglycosides and macrolides due to a nonsynonymous mutation within amrB which encodes an essential component of the AmrAB-OprA multidrug efflux pump (Podin et al., 2014) . While most of the Burkholderia spp. tested in this study were resistant towards azithromycin and gentamicin, 79% B. ubonensis had been shown to be susceptible to azithromycin and 42% susceptible to gentamicin. This observation suggests that B. ubonensis may possibly share the same mechanism as the majority of B. pseudomallei from central Sarawak, namely the AmrABOprA multidrug efflux pump, which conferred susceptibility towards aminoglycosides and macrolides. Nonetheless, this observation can only be confirmed by further studies to elucidate the antibiotics susceptibility mechanism in the B. ubonensis isolates tested in this study. Figure 1: Antibiotics susceptibility of Burkholderia spp. against azithromycin.
Cotrimoxazole susceptibility
As shown in Figure 3 , a majority of all the subspecies were susceptible to cotrimoxazole except for B. pyrrocinia where 17/31 (54%) were intermediately susceptible towards the antibiotics. In addition to that, 29% of the B. pyrrocinia tested were resistant towards cotrimoxazole. A majority of the Burkholderia spp. isolates tested in the present study were susceptible to cotrimoxazole, which is consistent with what was observed previously in B. pseudomallei (Dance et al., 1989; Jenney et al., 2001) . Cotrimoxazole is one of the important antibiotics prescribed in the eradication phase of melioidosis treatment regime which lasts for up to 20 weeks (Wiersinga et al., 2012) . Although there have been previous reports of cotrimoxazole resistance (Saiprom et al., 2015) , primary resistance is rare and most resistance occurred due to contraindication with amoxicillin/clavulanic acid (Wiersinga et al., 2012) . That 40% B. thailandensis and 30% of B. pyrrocinia tested in this study were resistant towards cotrimoxazole indicated that these two subspecies have different antibiogram profiles to that of B. pseudomallei. Certainly, this observation needs to be further confirmed using E-test which is more accurate especially when cotrimoxazole is a combination of trimethoprim/sulfamethoxazole. A previous work has described the bpeEF-oprC efflux pump as one of the mechanisms in conferring cotrimoxazole resistance in a strain of B. pseudomallei (Schweizer, 2012) . Whether this mechanism is shared by B. thailandensis and B. pyrrocinia remains to be determined in future studies. Notably, B. thailandensis, which has over 90% genomic similarities with B. pseudomallei is avirulent (Smith et al., 1997) . 
Ceftazidime susceptibility
All the Burkholderia spp. tested in the study were susceptible towards ceftazidime as shown in Figure 4 . This result is very reassuring considering that ceftazidime, a β-lactam, is one of the most important drugs in the intravenous phase treatment of melioidosis (Wiersinga et al., 2012) . While resistance against ceftazidime is rare, amino acid changes in the highly conserved class A ᵦ-lactam, PenA, has been attributed as one of the mechanisms for the resistance of ᵦ-lactams in B. pseudomallei (Sarovich et al., 2012) . 
CONCLUSION
More than half of the B. pyrrocinia and B. thailandensis tested in this study were shown to be either intermediately susceptible or resistant towards cotrimoxazole; different from what was observed in B. pseudomallei. When tested against aminoglycoside and macrolide, B. ubonensis exhibited similar profile with the unique strains of B. pseudomallei from the central region of Sarawak as described previously by Podin et al. (2014) , while the rest of the Burkholderia spp. were similar to the wildtype B. pseudomallei which make predominantly resistant to these two drug groups. Interestingly, all Burkholderia spp. tested were susceptible to ceftazidime, an important antibiotic in the treatment of melioidosis. It is apparent from the findings of this study that the antibiogram profile of Burkholderia spp. resembles that of B. pseudomallei for some antibiotics while totally different for other antibiotics. The mechanisms which render these observations and whether the interaction of these subspecies within the same ecological niche attribute to these observations warrant further investigation.
